DOCSLIB.ORG

Listing of Common Fatty Acids by Saturation First, Then Omega Family

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Listing of Common Fatty Acids by Saturation First, Then Omega Family Listing of Common Fatty Acids by Saturation first, then Omega Family The list below groups common fatty acids by their saturation level and omega family, and includes the shorthand name and primary sources for each type of fatty acid. The Saturated Fatty Acids Short-Chain Saturated Fatty Acid Butyric Acid (C4:0) Dairy Caproic Acid (C6:0) Dairy, goats Medium-Chain Saturated Fatty Acid Caprylic Acid (C8:0) Dairy milk, coconut Capric Acid ( C10:0) Milk, coconut, palm kernel Lauric Acid ( C12:0) Coconut, tropical oils Long-Chain Saturated Fatty Acid Myristic Acid ( C14:0) Nutmeg butter Pentadecanoic Acid (C15:0) Dairy Palmitic Acid ( C16:0) Fish, Dairy, Plant Margaric Acid ( C17:0) Goat milk, rare (also known as heptadecanoic Acid) Stearic Acid (C18:0) Animal, vegetable fats Arachidic Acid (C20:0) Peanut oil (also known as iIcosanoic Acid acid or, Eicosanoic Acid) Very-Long-Chain Saturated Fatty Acid Behenic Acid (C22:0) Plant, peanut, others Lignoceric Acid (C24:0) Plant, peanut Cerotic Acid (C26:0) Beeswax, carnauba wax The Unsaturated Fatty Acids This is a heads up that the proper names for fatty acids can be confusing. There is a more detailed description to the various names in the book. This is a simple list to acquaint the reader the common names you’ll likely come across when studying the plant oils. C = number of carbon atoms, :# = the number of double bonds in the FA. Monounsaturated Fatty Acids Omega 11 Gondoic/Eicosenoic Acid (C20:1) Marine, cod liver, whale oils Unsaturated Fatty Acids, Omega-10 Sapienic Acid (16:1) Human only Sabaleic Acid (18:2) Human only (Precious little information information exists for sabaleic available for it.acid, but I’ve left it in the list as new research may show it to be more important than it has been credited with to date.) Monounsaturated Fatty Acids, Omega-9 Oleic Acid (C18:1) Plant, Animal animal fat Ricinoleic Acid (C18:1) Castor beans Gadoleic/Eicosenoic Acid (C20:1) Cabbage, cod, and whale oils Erucic/Docosenoic Acid (C22:1) Seed oils, various Nervonic Acid (C24:1) Shark liver Monounsaturated Fatty Acids, Omega-8 Margaroleic Acid (C17:1) Marine, ? (Also known as heptadecenoic Acid) Monounsaturated Fatty Acids, Omega-7 Palmitoleic Acid, POA (C16:1) Animal, Plant mMarine (Also known as Hexadecenoic Acid) Vaccenic Acid (C18:1) Dairy, Animal animal fat Paullinic/Eicosenoic Acid (C20:1) Herring oil, Rapeseed Polyunsaturated Fatty Acids, Omega-6 Linoleic Acid, LA (C18:2) Seed, nNut oils Gamma-Linolenic Acid, GLA,(C18:3) EPO, Black Currant, Animal Eleostearic Acid (C18:3) Cherry Kernel Calendic Acid (C18:3) Calendula seeds Eicosadienoic Acid, EDA (C20:2) Animal, Marine Dihomo-gamma-linolenic Acid, DGLA (C20:3) trace amounts, rare Arachidonic Acid, AA (C20:4) Peanut, Animal, Egg (Also known as Eicosatetraenoic or Eicosanoic acid) Brassic/Docosadienoic Acid (C22:2) Cabbage, rare Polyunsaturated Fatty Acids, Omega 5 Eleostearic Acid (C18:3) Cherry kernel (Also called Octadecatrienoic Acid) Punicic Acid (C18:3) Pomegranate Myristoleic Acid (C14:1) Nutmeg Superunsaturated Fatty Acid, Omega-3 Alpha-Linolenic Acid LNA (C18:3) Plants; Flax, Hemp Stearidonic Acid SDA (C18:4) Hemp, Black Currant Eicosatetraenoic Acid ETA (C20:4) Shark liver, herring Timnodonic Acid EPA (C20:5) Marine, Animal (Also called Eicosapentaenoic Acid) Clupanodonic Acid DPA (C22:5) Animal liver, herring (Also called Docosapentaenoic Acid) Cervonic Acid DHA (C22:6) Marine, plant (Also called Docosahexaenoic Acid) .
Load more

Recommended publications
  • Effect of Propionic Acid on Fatty Acid Oxidation and U Reagenesis
    Pediat. Res. 10: 683- 686 (1976) Fatty degeneration propionic acid hyperammonemia propionic acidemia liver ureagenesls Effect of Propionic Acid on Fatty Acid Oxidation and U reagenesis ALLEN M. GLASGOW(23) AND H. PET ER C HASE UniversilY of Colorado Medical Celller, B. F. SlOlillsky LaboralOries , Denver, Colorado, USA Extract phosphate-buffered salin e, harvested with a brief treatment wi th tryps in- EDTA, washed twice with ph os ph ate-buffered saline, and Propionic acid significantly inhibited "CO z production from then suspended in ph os ph ate-buffe red saline (145 m M N a, 4.15 [I-"ejpalmitate at a concentration of 10 11 M in control fibroblasts m M K, 140 m M c/, 9.36 m M PO" pH 7.4) . I n mos t cases the cells and 100 11M in methyl malonic fibroblasts. This inhibition was we re incubated in 3 ml phosph ate-bu ffered sa lin e cont aining 0.5 similar to that produced by 4-pentenoic acid. Methylmalonic acid I1Ci ll-I4Cj palm it ate (19), final concentration approximately 3 11M also inhibited ' 'C0 2 production from [V 'ejpalmitate, but only at a added in 10 II I hexane. Increasing the amount of hexane to 100 II I concentration of I mM in control cells and 5 mM in methyl malonic did not impair palmit ate ox id ation. In two experiments (Fig. 3) the cells. fibroblasts were in cub ated in 3 ml calcium-free Krebs-Ringer Propionic acid (5 mM) also inhibited ureagenesis in rat liver phosphate buffer (2) co nt ain in g 5 g/ 100 ml essent iall y fatty ac id slices when ammonia was the substrate but not with aspartate and free bovine se rum albumin (20), I mM pa lm itate, and the same citrulline as substrates.
    [Show full text]
  • Chemical Synthesis of a Very Long-Chain Fatty Acid, Hexacosanoic Acid (C26:0), and the Ceramide Containing Hexacosanoic Acid
    J Nutr Sci Vitaminol, 61, 222–227, 2015 Chemical Synthesis of a Very Long-Chain Fatty Acid, Hexacosanoic Acid (C26:0), and the Ceramide Containing Hexacosanoic Acid Yoshinori YAMAMOTO, Toshimasa ITOH and Keiko YAMAMOTO* Laboratory of Drug Design and Medicinal Chemistry, Showa Pharmaceutical University, 3–3165 Higashi-Tamagawagakuen, Machida, Tokyo 194–8543, Japan (Received December 24, 2014) Summary Hexacosanoic acid (C26:0) (1), a very long-chain fatty acid, is related to vari- ous diseases such as adrenoleukodystrophy (ALD), adrenomyeloneuropathy (AMN) and atherosclerosis. As the level of 1 higher than the normal is related to diseases above, hexa- cosanoic acid (1) and the ceramide 2, which contains 1, are thought to play an important role in various tissues. Hexacosanoic acid (1) is known to be a waxy solid and to be hard to dissolve in water as well as organic solvents. Due to this physical property, it is not easy to handle hexacosanoic acid (1) in a laboratory. Therefore, efficient chemical synthesis of the compounds 1 and 2 has not been reported. Here, we report a versatile synthetic method for hexacosanoic acid (1) and the ceramide 2 containing the fatty acid 1. Synthesis of hexa- cosanoic acid (1) was achieved by applying the coupling of two alkyl units as a key step. Ceramide 2 was efficiently synthesized by applying the reported procedure together with hexacosanoic acid (1) synthesized here. This synthetic strategy has an advantage of getting various carbon chain length fatty acids and their ceramides by using a variety of carbon chain units. This method is also applicable for large-scale synthesis.
    [Show full text]
  • • Waxes Are Simple Lipids Containing Fatty Acid Joined to Long Chin Alcohol
    Waxes • Waxes are simple lipids containing fatty acid joined to long chin alcohol • They are esters of saturated long chain FA and long chain alcohol • In plants they are coatings that prevent water loss by leaves. • They are water insoluble soft solids with low melting point. • The can be obtained from – Insects – Minerals • Paraffin • Beeswax – Plants – Animal • Carnuba • Cocoa butter • Spermaceti 6/28/2020 1 Beeswax • Beeswax is the purified wax obtained from honeycomb of hive bee, Apis mellifera Linn and other species. • White beeswax is obtained by treating yellow beeswax chemically with potassium permanganate, chromic acid or chlorine or charcoal • When cold, yellow wax is brittle and when broken, shows presence of a dull, granular, non-crystalline fracture. • Yellow wax is insoluble in water and sparingly soluble in cold alcohol. • It is completely soluble in chloroform, ether, and fixed or volatile oils, partly soluble in cold benzene or in carbon disulphide. 6/28/2020 2 Beeswax… • Beeswax contains – myricin, which is melissyl palmitate; melting point 64°C, – Free cerotic acid (C26H52O2), – Myricyl alcohol (C30H61OH) – Melissic acid, some unsaturated acids of the oleic series, ceryl alcohol, and 12 to 13% higher hydrocarbons are present. • Beeswax is used in the preparation of ointments, plaster, and polishes. 6/28/2020 3 Cocoa butter • Synonyms: theobroma oil, cocao beans, semina theobromatis. • obtained from roasted seeds of Theobroma cacao Linn. • Cocoa seeds contain nearly 50% of cocoa butter. preparation Separation of seed from pod Fermentation at 30-40°C for 3-6 days Roasting at 100-140°C Cooling & nibbling Hot rolling to get butter Purification 6/28/2020 4 Cocoa butter… • Cocoa butter is yellowish white solid and brittle below 25°C.
    [Show full text]
  • Peroxisomal Fatty Acid Beta-Oxidation in Relation to the Accumulation Of
    Peroxisomal fatty acid beta-oxidation in relation to the accumulation of very long chain fatty acids in cultured skin fibroblasts from patients with Zellweger syndrome and other peroxisomal disorders. R J Wanders, … , A W Schram, J M Tager J Clin Invest. 1987;80(6):1778-1783. https://doi.org/10.1172/JCI113271. Research Article The peroxisomal oxidation of the long chain fatty acid palmitate (C16:0) and the very long chain fatty acids lignocerate (C24:0) and cerotate (C26:0) was studied in freshly prepared homogenates of cultured skin fibroblasts from control individuals and patients with peroxisomal disorders. The peroxisomal oxidation of the fatty acids is almost completely dependent on the addition of ATP, coenzyme A (CoA), Mg2+ and NAD+. However, the dependency of the oxidation of palmitate on the concentration of the cofactors differs markedly from that of the oxidation of lignocerate and cerotate. The peroxisomal oxidation of all three fatty acid substrates is markedly deficient in fibroblasts from patients with the Zellweger syndrome, the neonatal form of adrenoleukodystrophy and the infantile form of Refsum disease, in accordance with the deficiency of peroxisomes in these patients. In fibroblasts from patients with X-linked adrenoleukodystrophy the peroxisomal oxidation of lignocerate and cerotate is impaired, but not that of palmitate. Competition experiments indicate that in fibroblasts, as in rat liver, distinct enzyme systems are responsible for the oxidation of palmitate on the one hand and lignocerate and cerotate on the other hand. Fractionation studies indicate that in rat liver activation of cerotate and lignocerate to cerotoyl-CoA and lignoceroyl-CoA, respectively, occurs in two subcellular fractions, the endoplasmic reticulum and the peroxisomes but not in the mitochondria.
    [Show full text]
  • View Data Sheet
    PRODUCT DATA SHEET Hexacosanoic acid Catalog number: 1251 Molecular Weight: 397 Common Name: C26:0 Fatty acid; cerotic acid Storage: room temperature Source: synthetic Purity: TLC: 99%, GC >99% Solubility: chloroform, ethyl ether TLC System: hexane/ethyl ether/acetic acid CAS number: 506-46-7 (85:15:1 by vol.) Molecular Formula: C 26 H52 O2 Appearance: solid HO O Application Notes: This high purity very long chain fatty acid (VLCFA) is ideal as a standard and for biological studies. X-linked adrenoleukodystrophy (X-ALD) is an inherited disorder of peroxisomal metabolism and is characterized by deficient β- oxidation of saturated very long chain fatty acids such as hexacosanoic acid. Indeed, some studies show hexacosanoic acid as the most prevalent VLCFA in X-ALD, causing oxidative damage of proteins early on in the disease. 1 Hexacosanoic acid has also been found to be closely linked to a high risk of atherosclerosis and metabolic syndrome. 2 In plants, VLCFA are converted to long chain hydrocarbons which are used to make waxes that are essential to their survival. 3 VLCFA acylated to sphingolipids are critical in many biological functions 4 and substantial amounts are found to be amide-linked to the long- chain sphingoid base sphinganine, forming a ceramide, which constitutes the lipid backbone of sphingomyelin and other sphingolipids. VLCFA can often be found in esterified linkages with cholesterol, gangliosides, galactocerebrosides, sphingomyelin, and phosphatidylcholine. In myelin, VLCFA are important in increasing the structural stability. Selected References: 1. S. Fourcade et al. “Valproic acid induces antioxidant effects in X-linked adrenoleukodystrophy” Human Molecular Genetics , vol.
    [Show full text]
  • Fatty Acids: Essential…Therapeutic
    Volume 3, No.2 May/June 2000 A CONCISE UPDATE OF IMPORTANT ISSUES CONCERNING NATURAL HEALTH INGREDIENTS Written and Edited By: Thomas G. Guilliams Ph.D. FATTY ACIDS: Essential...Therapeutic Few things have been as confusing to both patient and health care provider as the issue of fats and oils. Of all the essential nutrients required for optimal health, fatty acids have not only been forgotten they have been considered hazardous. Health has somehow been equated with “low-fat” or “fat-free” for so long, to suggest that fats could be essential or even therapeutic is to risk credibility. We hope to give a view of fats that is both balanced and scientific. This review will cover the basics of most fats that will be encountered in dietary or supplemental protocols. Recommendations to view essential fatty acids in a similar fashion as essential vitamins and minerals will be combined with therapeutic protocols for conditions ranging from cardiovascular disease, skin conditions, diabetes, nerve related disorders, retinal disorders and more. A complete restoration of health cannot be accomplished until there is a restoration of fatty acid nutritional information among health care professionals and their patients. Fats- What are they? Dietary fats come to us from a variety of sources, but primarily in the form of triglycerides. That is, three fatty acid molecules connected by a glycerol backbone (see fatty acid primer page 3 for diagram). These fatty acids are then used as energy by our cells or modified into phospholipids to be used as cell or organelle membranes. Some fatty acids are used in lipoprotein molecules to shuttle cholesterol and fats to and from cells, and fats may also be stored for later use.
    [Show full text]
  • The Proportion of Nervonic Acid in Serum Lipids Is Associated With
    Journal of Oleo Science Copyright ©2014 by Japan Oil Chemists’ Society doi : 10.5650/jos.ess13226 J. Oleo Sci. 63, (5) 527-537 (2014) The Proportion of Nervonic Acid in Serum Lipids is Associated with Serum Plasmalogen Levels and Metabolic Syndrome Yuya Yamazaki1, Kazuya Kondo1, Ryouta Maeba2＊ , Megumi Nishimukai3, 4, Toru Nezu1 and Hiroshi Hara3 1 Food Development Laboratory, ADEKA Co., 7-2-34 Higashiogu, Arakawa-ku, Tokyo 116-8553, Japan 2 Department of Biochemistry, Teikyo University School of Medicine, 2-11-1 Kaga, Itabashi-ku, Tokyo 173-8605, Japan 3 ‌Division of Applied Bioscience, Research Faculty of Agriculture, Hokkaido University, Kita-9, Nishi-9, Kita-ku, Sapporo, Hokkaido 060-8589, Japan 4 Department of Animal Science, Faculty of Agriculture, Iwate University, 3-18-8 Ueda, Morioka, Iwate 020-8550, Japan Abstract: An increase in serum plasmalogens (1-O-alk-1-enyl-2-acyl glycerophospholipids), which are endogenous anti-oxidative phospholipids, can potentially prevent age-related diseases such as atherosclerosis and metabolic syndrome (MetS). Very long chain fatty acids (VLCFAs) in plasma may supply the materials for plasmalogen biosynthesis through peroxisomal beta-oxidation. On the other hand, elevated levels of saturated and monounsaturated VLCFAs in plasma appear to be associated with decreased peroxisomal function, and are a symptom of age-related diseases. To reconcile these contradictory findings, we attempted to investigate the relationship between the serum levels of saturated and monounsaturated VLCFAs, clinical and biochemical parameters, and serum levels of plasmalogens in subjects with MetS (n = 117), who were asymptomatic Japanese males over 40 years of age. Fatty acids in serum lipids were quantified using gas chromatography/mass spectrometry (GC/MS).
    [Show full text]
  • Fatty Acid Mass Spectrometry Protocol Updated 12/2010 by Aaron Armando
    Fatty Acid Mass Spectrometry Protocol Updated 12/2010 By Aaron Armando Synopsis: This protocol describes the standard method for extracting and quantifying free fatty acids and total fatty acids via negative ion chemical ionization GC-MS. Samples can be cells, media, plasma, or tissue. Methanol, HCl and deuterated internal standards are added to cell or media samples that are then extracted with iso-octane and derivatized to pentafluorobenzyl esters for GC analysis. Samples are then analyzed by GC-MS along with a standard curve consisting of unlabeled primary fatty acid standards mixed with the same deuterated internal standards added to the samples. The ratios of unlabeled to labeled standard are measured for the standard curve and used to determine unlabeled analyte levels for samples. All operating parameters for the instrument are contained in the raw data files, all other conditions are listed here. Storage: All samples and standards are stored under argon at -20°C. Internal Standards The internal standard contains 25 ng (0.25 ng/µl) of each of the following deuterated fatty acids in 100% ethanol: Name Abbrev. Company Amt. (mg) Cat. # Lauric Acid (d3) 12:0 CDN Isotopes 100 D-4027 Myristic Acid (d3) 14:0 Cambridge Isotopes 100 DLM-1039-0.1 Pentadecanoic Acid (d3) 15:0 CDN Isotopes 100 D-5258 Palmitic Acid (d3) 16:0 CDN Isotopes 100 D-1655 Heptadecanoic Acid (d3) 17:0 CDN Isotopes 100 D-5255 Stearic Acid (d3) 18:0 CDN Isotopes 100 D-1825 Oleic Acid (d2) 18:1 Cambridge Isotopes 100 DLM-689-0.1 Arachidic Acid (d3) 20:0 CDN Isotopes 0.1/200uL D-5254 Arachidonic Acid (d8) 20:4 Cayman Chemical 1/100uL 390010 Eicosapentaenoic Acid (d5) 20:5 Cayman Chemical 100 10005056 Behenic Acid (d3) 22:0 CDN Isotopes 0.1/200uL D-5708 Docosahexaenoic Acid (d5) 22:6 Cayman Chemical 100 10005057 Lignoceric Acid (d4) 24:0 CDN Isotopes 100 D-6167 Cerotic Acid (d4) 26:0 CDN Isotopes 100 D-6145 Stocks are maintained at 10X concentration (2.5 ng/ul) in 100% ethanol and diluted to working strength at extraction time.
    [Show full text]
  • Therapeutic Drug Monitoring of Antiepileptic Drugs by Use of Saliva
    REVIEW ARTICLE Therapeutic Drug Monitoring of Antiepileptic Drugs by Use of Saliva Philip N. Patsalos, FRCPath, PhD*† and Dave J. Berry, FRCPath, PhD† INTRODUCTION Abstract: Blood (serum/plasma) antiepileptic drug (AED) therapeu- Measuring antiepileptic drugs (AEDs) in serum or tic drug monitoring (TDM) has proven to be an invaluable surrogate plasma as an aid to personalizing drug therapy is now a well- marker for individualizing and optimizing the drug management of established practice in the treatment of epilepsy, and guidelines patients with epilepsy. Since 1989, there has been an exponential are published that indicate the particular features of epilepsy and increase in AEDs with 23 currently licensed for clinical use, and the properties of AEDs that make the practice so beneficial.1 recently, there has been renewed and extensive interest in the use of The goal of AED therapeutic drug monitoring (TDM) is to saliva as an alternative matrix for AED TDM. The advantages of saliva ’ fl optimize a patient s clinical outcome by supporting the man- include the fact that for many AEDs it re ects the free (pharmacolog- agement of their medication regimen with the assistance of ically active) concentration in serum; it is readily sampled, can be measured drug concentrations/levels. The reason why TDM sampled repetitively, and sampling is noninvasive; does not require the has emerged as an important adjunct to treatment with the expertise of a phlebotomist; and is preferred by many patients, AEDs arises from the fact that for an individual patient
    [Show full text]
  • Fatty Acids and Stable Isotope Ratios in Shiitake Mushrooms
    foods Article Fatty Acids and Stable Isotope Ratios in Shiitake Mushrooms (Lentinula edodes) Indicate the Origin of the Cultivation Substrate Used: A Preliminary Case Study in Korea 1, 1, 2 2 3 Ill-Min Chung y, So-Yeon Kim y, Jae-Gu Han , Won-Sik Kong , Mun Yhung Jung and Seung-Hyun Kim 1,* 1 Department of Crop Science, College of Sanghuh Life Science, Konkuk University, Seoul 05029, Korea; [email protected] (I.-M.C.); [email protected] (S.-Y.K.) 2 National Institute of Horticultural and Herbal Science, Rural Development Administration, Eumseong 27709, Korea; [email protected] (J.-G.H.); [email protected] (W.-S.K.) 3 Department of Food Science and Biotechnology, Graduate School, Woosuk University, Wanju-gun 55338, Korea; [email protected] * Correspondence: [email protected]; Tel.: +82-02-2049-6163; Fax: +82-02-455-1044 These authors contributed equally to this study. y Received: 22 July 2020; Accepted: 28 August 2020; Published: 1 September 2020 Abstract: Shiitake mushroom (Lentinula edodes) is commonly consumed worldwide and is cultivated in many farms in Korea using Chinese substrates owing to a lack of knowledge on how to prepare sawdust-based substrate blocks (bag cultivation). Consequently, issues related to the origin of the Korean or Chinese substrate used in shiitake mushrooms produced using bag cultivation have been reported. Here, we investigated differences in fatty acids (FAs) and stable isotope ratios (SIRs) in shiitake mushrooms cultivated using Korean and Chinese substrates under similar conditions (strain, temperature, humidity, etc.) and depending on the harvesting cycle. The total FA level decreased significantly by 5.49 mg g 1 as the harvesting cycle increased (p < 0.0001); however, no differences · − were found in FAs between shiitake mushrooms cultivated using Korean and Chinese substrates.
    [Show full text]
  • Study on Synthesis, Characterization and Antiproliferative Activity of Novel Diisopropylphenyl Esters of Selected Fatty Acids
    Journal of Oleo Science Copyright ©2016 by Japan Oil Chemists’ Society J-STAGE Advance Publication date : December 11, 2015 doi : 10.5650/jos.ess15151 J. Oleo Sci. Study on Synthesis, Characterization and Antiproliferative Activity of Novel Diisopropylphenyl Esters of Selected Fatty Acids Yasa Sathyam Reddy1, Shiva Shanker Kaki1, Bala Bhaskara Rao2, Nishant Jain2 and Penumarthy Vijayalakshmi1,＊ 1 Centre for Lipid Research, CSIR-Indian Institute of Chemical Technology (CSIR-IICT), Hyderabad 500007, Telangana, INDIA 2 Centre for Chemical Biology, CSIR-Indian Institute of Chemical Technology (CSIR-IICT), Hyderabad 500007, Telangana, INDIA Abstract: The present study describes the synthesis, characterization and evaluation of antiproliferative activity of novel diisopropylphenyl esters of alpha-linolenic acid (ALA), valproic acid (VA), butyric acid (BA) and 2-ethylhexanoic acid (2-EHA). These esters were chemically synthesized by the esterification of fatty acids with 2,6-diisopropylphenol and 2,4-diisopropylphenol (propofol). The structure of new conjugates viz. propofol-(alpha-linolenic acid) (2,6P-ALA and 2,4P-ALA), propofol-valproic acid (2,6P-VA and 2,4P-VA), propofol-butyric acid (2,6P-BA and 2,4P-BA) and propofol-(2-ethylhexanoic acid) (2,6P- 2-EHA and 2,4P-2-EHA) were characterized by FT-IR, NMR (1H, 13C) and mass spectral data. The synthesized conjugates having more lipophilic character were tested for antiproliferative in vitro studies on A549, MDA-MB-231, HeLa, Mia-Pa-Ca and HePG2 cancer cell lines. All the conjugates showed specific growth inhibition on studied cancer cell lines. Among the synthesized esters, the conjugates synthesized from BA, VA and 2-EHA exhibited prominent growth inhibition against A549, HeLa, Mia-Pa-Ca and HePG2 cancer cell lines.
    [Show full text]
  • YEAST SMELL LIKE WHAT THEY EAT: ANALYSIS of VOLATILE ORGANIC COMPOUNDS of Malassezia Furfur in GROWTH MEDIA SUPPLEMENTED WITH
    ! YEAST SMELL LIKE WHAT THEY EAT: ANALYSIS OF VOLATILE ORGANIC COMPOUNDS OF Malassezia furfur IN GROWTH MEDIA SUPPLEMENTED WITH DIFFERENT LIPIDS " THESIS PRESENTED AS PARTIAL REQUIREMENT TO OBTAIN THE TITLE AS MASTER OF SCIENCE IN CHEMISTRY Presented by: MABEL CRISTINA GONZÁLEZ MONTOYA Advisor CHIARA CARAZZONE, Ph.D. Co-advisor ADRIANA M. CELIS, Ph.D." ! CHEMISTRY DEPARTMENT UNIVERSIDAD DE LOS ANDES DECEMBER 2018 BOGOTÁ D.C. ! ! !2 CONTENT 1. ABSTRACT................................................................................................................................... 6 2. ACKNOWLEDGEMENTS ............................................................................................................7 3. INTRODUCTION TO THE GENERAL TOPIC............................................................................. 8 4. PROBLEM STATEMENT AND JUSTIFICATION OF THE RESEARCH PROJECT................... 9 5. OBJECTIVES OF THE STUDY.................................................................................................. 10 5.1. General objective............................................................................................................... 10 5.2. Specific objectives............................................................................................................. 10 6. THEORETICAL FRAMEWORK................................................................................................. 10 6.1. Microbial and fungal VOCs..............................................................................................
    [Show full text]